Edwards Lifesciences Corporation
EW
#476
Rank
$52.326 B
Marketcap
United States
Country
$90.78
Share price
-3.07%
Change (1 day)
19.76%
Change (1 year)
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and…
Key Metrics
Trailing P/E
53.16
Forward P/E
26.13
EPS (TTM)
$1.66
Forward EPS
$3.38
Price / Book
4.79
EV / EBITDA
23.8x
Beta
0.85
Dividend Yield
—
Return on Equity
9.18%
Return on Assets
8.37%
Debt / Equity
6.57
Current Ratio
4.52
Gross Margin
77.84%
Operating Margin
29.84%
Net Profit Margin
15.43%
Free Cash Flow
$1.232B
Charts
Price history and financial performance over time.
Price & Market Cap
Aug 19 – Sep 16
-3.25%
Source: Yahoo Finance daily closes. Market cap uses the closest quarterly shares-outstanding filing for each date.
Revenue & Net Income
Annual · USD
RevenueNet Income
Latest Revenue$6.068B
Latest Net Income$1.073B
Reporting periods4
Source: Yahoo Finance annual income statements. Year is the fiscal-year end. Most recent period may be trailing-twelve-month (TTM) until the next 10-K is filed.
Compare Edwards Lifesciences Corporation with competitors
Side-by-side market cap, revenue, and financial comparison.
Latest News
Latest News
EW
No recent news available. Set FINNHUB_API_KEY to enable news.
